FAS and polycystic ovary syndrome: Swertiamarin (P < 0.001) significantly down regulated the candidate genes viz SREBP1c, FAS, ACC-1 and CPT-1 in PCOS-IR as compared to PCOS-NIR where it did not show any effect.